Last updated on November 2018

FASENRA SCEI for Long-term Use


Brief description of study

The purpose of the investigation is to confirm the safety and efficacy under the post-marketing actual long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.

Detailed Study Description

The purpose of the investigation is to confirm the followings under the post-marketing actual long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.

  1. Detection of unexpected Adverse Drug Reactions
  2. To grasp development of Adverse Drug Reactions
  3. To grasp contributing factors possibly having an impact on the safety and efficacy
  4. Development of key investigational safety specification (serious infection).

Clinical Study Identifier: NCT03588546

Contact Investigators or Research Sites near you

Start Over

AstraZeneca Clinical Study Information Center

Research Site
Tochigi, Japan
0.73miles
  Connect »